Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DeathXray33on Dec 10, 2023 5:18pm
149 Views
Post# 35777058

RE:RE:RE:An example of deceptive headlines for Adstiladrin

RE:RE:RE:An example of deceptive headlines for Adstiladrin
StevenBirch wrote: Well let's hope the FDA sees through deceptive headlines like that, I'm sure they do just like I'm sure Roger knows they do. Doesn't TLT really have the trifecta - better CR numbers, fewer AE's and fewer/less invasive treatments than the competition? I'm going to assume that all companies in this field go through the same machinations and frustrations that we are going through before actually breaking through. Ours may be a little worse because of the financial tightrope Roger is walking but I'm hoping that is for our/his own good in the end. Of course we won't find out until we get that approval.


Asstilladrin (a mess). Merc made a messtake... They shall soon see...
<< Previous
Bullboard Posts
Next >>